TDEs from breast cancer cells receiving radiotherapy triggered the DNA damage repair response (DDR) such as ataxia telangiectasia-mutation (ATM) by increasing the phosphorylation of histone H2AX and checkpoint kinase 1 (CHK1) in recipient cells [133]. The gene discussed is ATM; the disease is breast carcinoma.